Dr Schierhout has a lead role in developing a program of work at the institute focused on evaluating interventions of public health significance and large-scale programs in health. Her research work is underpinned by qualitative, quantitative, and mixed methods expertise and decades of experience conducting evaluations closely with and for health system stakeholders globally and in many different countries in Africa and Asia-Pacific. She has published widely and is lead or chief investigator on a number of grants and commissioned research projects focused on evaluating innovative policy reforms and programs to improve the access and quality of primary care, particularly for disadvantaged groups.

Dr Paul Schreier joins The George Institute’s Board as Chair on 1 March 2025. He is the CEO of SimplyHealth, one of the UK’s leading health providers founded in 1872.  

Previously, Paul was the Interim CEO of the Wellcome Trust, a global charitable foundation focused on health research. Paul led Wellcome’s efforts on COVID-19 treatments and was a member of the investment committee. He was also the global therapeutics co-lead of the World Health Organization’s Accelerating COVID Tools partnership. 

Paul’s commercial and public sector experience includes service in the Royal Navy, and as a partner in McKinsey & Company in London and Kuala Lumpur, latterly establishing the firm’s office in Hanoi. Returning to Australia, he was deputy secretary in the Department of the Prime Minister and Cabinet, with responsibility for economic policy and strategy, and Deputy Vice-Chancellor and Chief Operating Officer at Macquarie University in Sydney. He returned to the UK in 2016 to lead Hakluyt & Company, a professional services firm. He is the former chair of the Sanger Institute near Cambridge, and has served on the boards of the Francis Crick Institute and the National Army Museum in London, as well as the strategic advisory council of the India Alliance, which funds research in health based in Hyderabad.